Telomere syndromes have their most common manifestation in lung disease that is recognized as idiopathic pulmonary fibrosis and emphysema. In both conditions, there is loss of alveolar integrity, but the underlying mechanisms are not known. We tested the capacity of alveolar epithelial and stromal cells from mice with short telomeres to support alveolar organoid colony formation and found that type 2 alveolar epithelial cells (AEC2s), the stem cellcontaining population, were limiting. When telomere dysfunction was induced in adult AEC2s by conditional deletion of the shelterin component telomeric repeat-binding factor 2, cells survived but remained dormant and showed all the hallmarks of cellular senescence. Telomere dysfunction in AEC2s triggered an immune response, and this was associated with AEC2-derived up-regulation of cytokine signaling pathways that are known to provoke inflammation in the lung. Mice uniformly died after challenge with bleomycin, underscoring an essential role for telomere function in AEC2s for alveolar repair. Our data show that alveoloar progenitor senescence is sufficient to recapitulate the regenerative defects, inflammatory responses, and susceptibility to injury that are characteristic of telomere-mediated lung disease. They suggest alveolar stem cell failure is a driver of telomere-mediated lung disease and that efforts to reverse it may be clinically beneficial.
telomerase | idiopathic pulmonary fibrosis | emphysema | senescence M utations in telomerase and telomere genes cause abnormal telomere shortening. Clinically, this molecular abnormality manifests in a spectrum of telomere syndromes that recapitulate features of age-associated pathology (1) . In highly proliferative compartments, such as the bone marrow, telomere dysfunction causes stem cell exhaustion, and hematopoietic stem cell transplantation can reverse this pathology (1) . More commonly, short telomeres predispose to adult-onset disease in the lung, a tissue that has slow cell turnover (1) . Idiopathic pulmonary fibrosis and emphysema are the most prevalent clinical manifestations of human telomere syndromes and account for more than 80% of presentations (1, 2) . The alveolar structures are preferentially affected in these disorders, and their pathology is marked by inflammation and mesenchymal abnormalities (3, 4) . Affected patients are also exquisitely sensitive to pulmonary-toxic drugs, which are fatal even when there is no detectable baseline lung disease (1, 5) .
The mechanisms by which telomere defects provoke lung disease are not understood, but a number of observations have pointed to lung-intrinsic factors and epithelial dysfunction as candidate events (6) (7) (8) (9) (10) . For example, in telomerase-null mice, DNA damage preferentially accumulates in the air-exposed epithelium after environmentally induced injury, such as with cigarette smoke (7) . The additive effect of environmental injury and telomere dysfunction has been suggested to contribute to the susceptibility to emphysema seen in these mice (7) . Moreover, humans that carry mutations in the surfactant protein C gene, SFTPC, which is expressed exclusively in type 2 alveolar epithelial cells (AEC2s), develop lung disease phenotypes similar to those seen in telomerase mutation carriers (10) (11) (12) . Pulmonary fibrosis and emphysema patients have also been noted to have abnormally short telomeres in AEC2s (6, 7, 13). These observations, along with AEC2s' regenerative capacity (14) (15) (16) , led us to hypothesize that telomere dysfunction is sufficient to provoke AEC2 failure and that this event drives lung disease pathogenesis.
One hurdle to modeling the consequences of telomere dysfunction in a cell type-specific manner is that laboratory mice have very long telomeres (17) . In the absence of telomerase, telomere dysfunction can be generated only after several generations of breeding, precluding cell type-specific studies (18) . To overcome this limitation, we designed two experimental systems. First we examined the role of telomere shortening in purified AEC2s in a stem cell assay ex vivo. For an in vivo system, we generated a model in which telomere dysfunction can be induced by deleting telomeric repeat-binding factor 2 (Trf2) (19, 20) exclusively in adult AEC2s. Trf2 functions to suppress the DNA damage response, and its loss leads to telomere dysfunction by uncapping, thus allowing cell typespecific studies within a single generation (19, 20) . The latter surrogate model allowed us to test the consequences of acquired DNA damage and telomere dysfunction in the adult lung. We show here, in both late-generation telomerase-null mice and in a conditional mutant model, that telomere dysfunction restricted to AEC2s impairs stem cell function by inducing senescence. This program recapitulates the inflammatory responses and susceptibility to injury that are hallmarks of telomere-mediated lung disease.
Significance
Idiopathic pulmonary fibrosis and emphysema are leading causes of mortality, but there are no effective therapies. Mutations in telomerase are the most common identifiable risk factor for idiopathic pulmonary fibrosis. They also predispose to severe emphysema in smokers, occurring at a frequency similar to α-1 antitrypsin deficiency. The work shown here points to alveolar stem cell senescence as a driver of these pathologies. Epithelial stem cell failure was associated with secondary inflammatory recruitment and exquisite susceptibility to injury from "second hits." The findings suggest that efforts to reverse the stem cell failure state directly, rather than its secondary consequences, may be an effective therapy approach in telomere-mediated lung disease.
Results
Short Telomeres in AEC2s Limit Alveolosphere Formation. We had previously shown that telomerase-null mice, mTR −/− , with short telomeres are more susceptible to cigarette smoke-induced lung injury because of lung-intrinsic defects (7). We therefore first tested the capacity of alveolar stromal cells and AEC2s derived from these mice to support alveolar regeneration in vitro. In this system, primary AEC2s are cultured with freshly isolated stromal cells marked by platelet-derived growth factor receptor α (Pdgfrα) to generate clonally derived, organoid colonies termed "alveolospheres" (Fig. 1A) (14) . These structures are comprised exclusively of AEC2s that have both self-renewed and differentiated into type 1 alveolar epithelial cells (AEC1s) (14) . We found that Pdgfrα + stromal cells isolated from mTR −/− mice with short telomeres supported normal colony formation when cultured with wild-type AEC2s (Fig. 1B) . In contrast, AEC2s derived from late-generation mTR −/− mice generated significantly fewer colonies when cultured with wild-type stromal cells (P = 0.038) (Fig. 1C) . This defect was dependent on telomere length and did not depend on telomerase deletion, because only AEC2s from mTR −/− fourthgeneration mice that had short telomeres and an up-regulated DNA damage response had this impairment, while AEC2s from first-generation mice had intact colony-forming capacity ( Fig. 1  C and D and Fig. S1A ). These data indicated that abnormally short telomeres preferentially limited AEC2 regenerative capacity and that this defect was cell-autonomous.
Telomere Dysfunction in Adult AEC2s Preferentially Induces Senescence.
To test the consequences of epithelial-restricted telomere dysfunction on alveolar homeostasis, we generated a model in which it can be induced in adult AEC2s. Telomere shortening is gradual in the absence of telomerase, and because laboratory mice have long telomeres, telomere dysfunction occurs only after four to six generations of breeding, thus precluding cell type-specific studies (17, 18) . We generated a conditional model in which DNA damage at telomeres can be induced in a single generation by deleting Trf2. We crossed Sftpc-CreER mice with mice carrying a floxed allele of Trf2 (20) (21) (22) Sftpc-CreER mice (4% and 7% of control levels on days 7 and 21, respectively) ( Fig. S1 B-F) . The deletion of Trf2 resulted in a robust induction of the DNA damage response at telomeres as evidenced by p53-binding protein 1 (53BP1) foci ( Fig. 2 A and B) . The telomere dysfunction was specific, because the DNA damage foci were detected only in AEC2s and not in neighboring bronchiolar epithelial cells (Fig. 2B) . The p53 pathway was also activated, as evidenced by up-regulation of its target genes in freshly isolated AECs, including p21, Bax, Ccng1, and Mdm2; this signal was detected in vivo for days after Trf2 deletion (Fig. 2C) . These data indicated that the induction of the DNA damage response was specific and durable in adult AEC2s.
We examined the consequences of telomere dysfunction on AEC2 survival but found no increase in apoptosis [TUNEL assay and cleaved caspase-3 (CC3) (Fig. S1 G and H) ]. Instead, the Trf2-deleted AEC2s persisted when we lineage traced their fate using a reporter line (Fig. 2D ). When we measured the proliferation rate, we found that EdU (a BrdU analog) incorporation was significantly lower in AEC2s from Trf2
Fl/Fl ;Sftpc-CreER mice than in AEC2s from controls (14-d label, P < 0.001, Fig. 2E ). Notably, although the baseline proliferation rate in tamoxifen-treated mice was higher than we had documented previously in tamoxifenfree mice (7), the proliferation in AEC2s with dysfunctional telomeres was significantly blunted (Fig. 2E) . Taken together, the upregulated DNA damage response, p53 pathway signaling, and the persistence of AEC2s suggested that AEC2s with Trf2 deletion preferentially activated a cellular senescence program in vivo.
Trf2 Deletion Limits Self-Renewal and Differentiation of Alveolar Stem Cells. To test whether the loss of telomere function affected the regenerative potential of AEC2s, we isolated lineagelabeled cells from Trf2
Fl/Fl ;Sftpc-CreER lungs and examined their capacity to self-renew and differentiate in the alveolosphere assay. Cre-expressing AEC2s were labeled with a GFP reporter, allowing us to track their fate in culture. At baseline, the fraction of GFP + AEC2s in vivo was similar in control and experimental mice (Fig. 2F) . However, once the AEC2s were seeded and challenged to generate colonies, Trf2-deleted AEC2s failed to form alveolospheres (0.3 vs. 209 and 0.5 vs. 425 per 5,000 AEC2s on days 7 and 14, respectively; P < 0.001) (Fig. 2 G and H) . Moreover, although control AEC2s formed clonally derived AEC2s and AEC1s, Trf2-depleted cells did not differentiate and remained arrested on day 21 ( Fig. 2 I and J) . These data established that telomere dysfunction induced by Trf2 deletion caused alveolar stem cell failure because of a proliferative arrest, the hallmark of cellular senescence.
Epithelial-Restricted Defects Are Sufficient to Recruit Inflammation.
We next examined whether telomere dysfunction in adult AEC2s affected lung function. Trf2 ;Sftpc-CreER mice had no respiratory distress or weight loss, but pulmonary function studies showed they acquired an expanded total lung capacity and residual volume (Fig. 3A and Fig.  S2 A and B) . These abnormalities were accompanied by an increase in lung compliance (Fig. S2C) . Although mean linear intercepts were statistically similar on average, in 2 of 30 (7%) of the experimental mice, there was significant air space enlargement (>2 SDs above the mean in controls) (Fig. 3B) . Bronchoalveolar lavage fluid from experimental mice contained a significantly increased leukocyte fraction that was composed predominantly of macrophages but also included lymphocytes ( Fig. 3 C and D) . There was also parenchymal inflammation that was graded as moderate or severe in four of nine experimental mice (compared to 1 of 13 controls), and quantification of macrophages by immunohistochemistry documented an increase (P = 0.04) ( Fig. 3 E-I ). The inflammatory infiltrates were prominent in perivascular areas surrounding the distal bronchioles, as is consistent with systemic recruitment ( Fig.  3 G and H). The macrophages were notably iron-laden (Fig. 3F) ; this abnormality is associated with cigarette smoke-induced lung disease and diffuse alveolar damage in humans. The lymphocytic infiltrate was CD3 + , consistent with T-cell recruitment (Fig. S2 D-F), and also similar to the patterns seen in human smokers with lung disease (23) . These data established that DNA damage at telomeres in adult AEC2s is sufficient to recruit a robust inflammatory response.
AEC2s with Telomere Dysfunction Up-Regulate Immune-Signaling
Pathways. To define the mechanism by which epithelial-restricted telomere damage recruits inflammation, we performed a geneexpression microarray analysis on sorted AEC2s isolated from tamoxifen-treated Trf2
Fl/Fl ;Sftpc-CreER and Trf2
Fl/+ ;Sftpc-CreER mice. We found an altered profile with 162 differentially upregulated and 1,361 down-regulated genes in Trf2-deleted AEC2s (Fig. 3J ). Among the differentially up-regulated genes, Il17c, encoding interleukin 17c, and Mif, encoding macrophage inhibitory factor, were notable because they are known to trigger epithelial-derived innate immune responses in the lung (24-26) (real-time PCR confirmation is shown in Fig. S2G ). Moreover, the highest-fold up-regulated genes fell in immune-signaling and inflammation pathways in addition to the DNA damage response ( Fig. 3K and Table S1 ). Specifically, one-fourth of the pathways with the highest statistical significance (6 of 23) fell in immune-cytokine signaling even though these pathways represented only a minority of the total examined (significance defined as P ≤ 0.1, Fisher's exact test). Notably among them was Il15 signaling, which has been implicated in T-cell recruitment in the lung ( Fig. 3K ) (27) . These observations indicated that the telomere dysfunction induced by Trf2 deletion altered the AEC2 transcriptome globally and upregulated immune-signaling pathways.
Telomere Dysfunction in AEC2s Predisposes to Fatal Lung Disease
After Injury. To test whether telomere dysfunction in AEC2s was relevant to the response to injury, we challenged mice with are expressed as mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001, Student's t test.
bleomycin. We chose this model because patients with telomere syndrome are exquisitely susceptible to pulmonary-toxic drugs, such as bleomycin and busuflan, (1, 28) . Trf2
Fl/Fl ;Sftpc-CreER mice that were given bleomycin developed a severe systemic illness marked by accelerated weight loss (Fig. 3L ). This pathology was associated with increased mortality, and 100% of mice died by day 29 (11 of 11 in the experimental group vs. 10 of 19 in the control group; P = 0.003, log-rank test) (Fig. 3M) . The early mortality in the first 2 weeks in a majority of experimental mice (64%) suggested that acute epithelial injury was a likely cause of respiratory failure. In the mice that we could study premortem, there was no difference in collagen content, apoptosis, or burden of inflammation. However, Trf2-depleted AEC2s showed proliferative defects similar to those we saw in the absence of injury (P = 0.037) (Fig. 3N ).
Telomere Dysfunction in Sftpc + Cells Signals Mesenchymal Abnormalities.
We next generated a congenital model surmising that telomere dysfunction during development in epithelial cells would cause severe lung defects and that this model would allow us to examine the downstream effectors of telomere dysfunction. We studied Trf2 Fl/Fl ; Sftpc-Cre mice in which Cre recombinase is expressed constitutively and Trf2 is thus deleted in epithelial progenitors during lung development. Mice were born at Mendelian ratios, but Trf2
Fl/Fl ;SftpcCre mice died from cyanosis and a lung morphogenesis defect within hours after birth, whereas their Trf2 Fl/+ ;Sftpc-Cre littermates survived and had no abnormalities (Fig. 4 A and B and Fig. S3A ). Similar to the adult model, the DNA damage response and p53 pathway activation were restricted to epithelial cells (Fig. 4C and Fig. S3 B and  C) . However, in this developmental context, the response to telomere dysfunction was more severe and manifested in a profound proliferative defect as well as apoptosis (Fig. 4 F and G and Fig. S3 D and E). Importantly, there was extensive secondary mesenchymal apoptosis even though the DNA damage response was limited to epithelial cells (Fig. 4G and Fig. S3G ). Trf2
Fl/Fl ;Sftpc-Cre mice that were bred to the Rosa-mTmG reporter line also confirmed epithelial-restricted Cre expression (Fig. S3H) . These data indicated that telomere dysfunction in epithelial cells is sufficient to signal mesenchymal abnormalities.
The Epithelial-Derived Paracrine Signal Is p53 Dependent in the Developing Lung. Because the response to telomere dysfunction is mediated by p53 in some contexts (29-31), we generated compound mutant Trf2
Fl/Fl ;Sftpc-Cre mice that were also null for p53. The p53 deletion resulted in significant amelioration of the lung morphogenesis defect (Fig. 4 D and E) . The rescue occurred because p53 deletion abrogated the apoptotic response in epithelial and mesenchymal cells simultaneously, while effectively abolishing p53 downstream effectors including p21 and Bax (Fig. 4 F-I) . However, the p53-mediated rescue was partial and did not sustain the survival of newborn pups. To test whether the mesenchymal survival advantage was the result of an epithelialderived p53 signal, we generated Trf2
Fl/Fl ;Sftpc-Cre;p53
Fl/Fl mice in which p53 deletion was limited to Sftpc-expressing cells. In this experiment, we found the conditional deletion recapitulated the lung morphogenesis rescue seen in constitutively p53 −/− mice and was also sufficient to rescue mesenchymal cell survival (Fig. 4 D-G) . These data, taken together, indicated that telomere dysfunction in Sftpc + cells signaled mesenchymal abnormalities in a paracrine manner that was p53 dependent.
Discussion
Telomere Dysfunction in AEC2s Recapitulates Features of TelomereMediated Disease. The data we report here shed light on how telomere dysfunction disturbs alveolar homeostasis in disease and point to an important role for alveolar stem cell failure. Short telomeres limited alveolar regenerative capacity in telomerase-null mice, indicating a cell-autonomous defect. In a conditional model, telomere dysfunction and the consequent induction of DNA damage provoked alveolar stem cell senescence. The conditional model we developed allowed us to overcome an intrinsic hurdle to studies in telomerase-null mice and to dissect the driving events in telomere-mediated lung disease (Table S2) . Induction of telomere dysfunction in adult AEC2s was sufficient to provoke lung function abnormalities, secondary inflammation, and catastrophic responses to pulmonary toxic drugs, all features of telomere-mediated lung disease. These observations, in light of our data in telomerase-null mice, indicate that alveolar stem cell failure alone can recapitulate key features of telomere-mediated lung pathology. Dysfunctional telomeres and biomarkers of senescence have been well documented in alveolar epithelial cells from diseased human lungs (6, 13) . However, the complexity of the human pathology, in both fibrosis and emphysema, does not distinguish driver from secondary bystander events. Our data in genetically defined animal models indicate that AEC2-dependent telomere dysfunction and senescence limit alveolar repair and can signal mesenchymal abnormalities.
Senescence Is a Preferred Response to Telomere Dysfunction in
Alveolar Epithelial Cells. The data we present here highlight a contrast in the response to telomere dysfunction between high-and lowturnover tissues. In the hematopoietic system, telomere dysfunction causes stem cell failure because of replicative exhaustion, and this phenotype is clinically evident in mice and limits their survival (32) (33) (34) (35) . In contrast, when telomere dysfunction is restricted to AEC2s, a population with a comparatively slow turnover, the clinical phenotype is fairly well tolerated de novo. However, after injury with a "second hit," the response is catastrophic, as we saw after bleomycin challenge. Human telomere-mediated lung disease similarly represents an attenuated clinical phenotype that becomes symptomatic in late adulthood, on average four decades later than bone marrow failure, reflecting a more slowly evolving process (36) . However, in telomerase mutation carriers, exposure to cigarette smoke and pulmonary toxic drugs are known to provoke exacerbations and functional declines that culminate in respiratory failure Data are expressed as mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001, Student's t test. (7, 8, 36, 37) . The cellular responses to telomere dysfunction are also distinct. In high-turnover epithelial tissues such as the intestinal tract, telomere dysfunction preferentially induces apoptosis (32, 33, 38) . On the other hand, AEC2s, in both short-telomere mice (7) and in the conditional model we generated, preferentially undergo senescence. The cellular senescence response may be particularly advantageous in the alveolar space because epithelial cells serve a critical barrier function, and their persistence, even when they have activated a senescence program, preserves the integrity of air exchange.
AEC2 Senescence Signals Secondary Paracrine Abnormalities. A synthesis of the data we show supports a model in which AEC2 senescence simultaneously causes cell-autonomous defects and up-regulates secondary paracrine signals. In addition to the profound proliferative defects we observed in and ex vivo, we documented evidence of epithelial-derived paracrine signaling that induced inflammation and secondary mesenchymal abnormalities. Telomere-mediated senescence has been associated with altered gene expression as well as an in vitro secretory phenotype (known as "SASP") in cultured human cells (39, 40) . The data we report here show that telomere dysfunction causes senescence-associated paracrine signaling in vivo within the alveolar space that is marked by global transcriptional alterations. This program may be a primary driver of the inflammatory pathology seen in telomere-mediated lung disease. Although more work is needed to characterize the immune responses driven by epithelial senescence, it is noteworthy that the macrophage and T-cell predominance of the infiltrates recapitulate those seen in cigarette smoke-induced lung disease (23) . These results raise the possibility that inhibiting inflammation, without reversing the upstream alveolar epithelial defect, may not change the natural history or improve clinical outcomes significantly for patients with telomere-mediated lung disease. Instead, therapy strategies aimed at restoring telomere function or reestablishing epithelial regenerative capacity may be more beneficial.
Methods
Mice were housed at the Johns Hopkins University School of Medicine campus, and procedures were approved by its Institutional Animal Care and Use Committee. Detailed methods outlining the mouse strains, animal studies, alveolar cell isolation along with the immunostaining and RNA analyses are supplied in SI Methods. ," "p53 −/− ," "p53 Fl/Fl ," and "Rosa-mTmG," respectively) were purchased from the Jackson Laboratory. mTR −/− , SftpcCre, and Sftpc-CreER mice were generated as previously described (5-7). All mouse strains were on the C57BL/6J background except those involving the Rosa-mTmG reporter line, which was on a mixed B6/129 background.
Supporting Information
Tamoxifen (5 mg) (Sigma) was administered intraperitoneally (i.p.) on days 1 and 3. In one experiment, tamoxifen was mixed with the diet for 21 d (TD.130856; Harlan Laboratories). For experiments involving Sftpc-CreER mice, sex-matched 8-to 12-wk-old mice were studied. Otherwise, the ages of mice are noted in figure legends. Proliferation studies in adult mice were carried out by implanting a 14-d miniosmotic pump (Alzet) containing 10 mg/mL EdU, a nucleotide analog, dissolved in sterile saline as described (8) . For 72-h experiments, 100 μg EdU was delivered i.p. daily.
AEC2 Cell Isolation and Alveolosphere Assay. Single-cell suspensions of minced lungs were prepared as described with a few modifications (9) . Briefly, mice were euthanized by isoflurane inhalation or Euthasol (pentobarbital sodium and phenytoin sodium; Virbac) followed by transection of the inferior vena cava. The lungs were perfused with 5 mL PBS. Lungs were inflated with 1 mL digest solution containing 450 U/mL collagenase type I (Gibco), 4 U/mL elastase (Worthington Biochemical Corporation,), 5 U/mL dispase (BD Biosciences), and 0.33 U/mL DNaseI (Roche) in DMEM/F12 or PBS (Gibco). After inflation, the trachea was ligated, and the lungs were removed and placed in 3 mL of digest solution. Lung tissue was minced and incubated at 37°C for 30 min with frequent agitation. The cell suspension was passed through a 70-μM filter, red cell lysed, and suspended in DMEM/F12 with 2% FBS. Cells were sorted on a Becton Dickinson FACSAria IIu or FACS Vantage SE. Analyses were performed using FlowJo software (TreeStar Inc.).
For alveolosphere assays using non-lineage-labeled AEC2s, we stained single-cell suspensions and gated based on the following criteria: positive for EpCAM and negative for CD31/CD45/ podoplanin/Sca1/CD24/PI. For isolation of non-lineage-labeled stromal cells, we gated positive for Pdgfrα and negative for EpCAM/CD31/CD45. For antibody staining, cells were placed in staining solution (1× PBS with 2% BSA and 2% FBS). They were blocked in staining solution with TruStain fcX (BioLegend). Antibody were obtained as follows: EpCAM PE-Cy7, CD31 biotin, and CD45 biotin from eBioscience. PE/Cy5 streptavidin, podoplanin PE, Sca-1 488, CD24 BV421, and PDGFRα/CD140a APC were purchased from BioLegend.
Alveolosphere assays were performed as described (2) . Briefly, AEC2 cells were plated in MTEC/Plus and were mixed with growth factor-reduced Matrigel (BD Biosciences). Then 5 × 10 3 AEC2s and 1 × 10 5 PDGFRα-GFP hi cells were plated into a 24-well Transwell insert (Falcon), and 500 μL MTEC/Plus was placed in the lower chamber. PDGFRα-GFP hi cells (1 × 10 5 ) were plated alone to measure contaminating epithelial cells from stromal donors. Rho-associated coiled-coil containing protein kinase (ROCK) inhibitor (10 μM; Y0503; Sigma-Aldrich) was included in the medium for the first 2 d of culture, which was at 37°C in 5% CO 2 /air (2). For alveolosphere assays of lineage-labeled cells,
GFP
+ cells were flow sorted and mixed with lineage-labeled stromal cells as described (2) .
For immunohistochemistry of alveolosphere colonies, the Matrigel disk was removed, dehydrated through ethanol, and transitioned into paraffin as described (10) . All quantification is based on triplicate values for each mouse at each time point. All alveolosphere assays were harvested and analyzed blinded to mouse genotypes.
Immunohistochemistry and Immunofluorescence. Tissue sections were harvested from adult lungs and prepared using the detailed protocols previously outlined (8) . Sorted cells were prepared for immunofluorescence using a Cytospin 3 centrifuge (Thermo Scientific) and were fixed in fresh 4% paraformaldehyde (PFA) for 10 min followed by permeabilization in 0.3% Triton X-100. Antibodies were obtained from the following sources: E-cadherin, γH2AX, p53
Ser15
, and cleaved caspase-3 from Cell Signaling; proSpc from Chemicon; E-cadherin for whole-mount studies from Life Technologies; 53BP1 from Novus Biologicals; Club cell antigen from Santa Cruz Biotechnologies; CD3 from Abcam; GFP from Aves Labs; Mac-3 and p21 from BD Biosciences; and podoplanin (hamster) from Developmental Studies Hybridoma Bank (Clone 8.1.1). The ABCA3 antibody (guinea pig) was generously provided by Jeffrey Whitsett (University of Cincinnati, Cincinnati). Secondary antibodies conjugated to Alexa-488, Alexa-594, or Alexa-647 were purchased from Life Technologies. EdU staining was performed using a Click-iT imaging kit (Life Technologies). Telomere length on AEC2s was measured as previously described (8) . Images were analyzed using the Telometer: Software for Telomere Counting as described previously at demarzolab.pathology.jhmi. edu/telometer/. Telomere dysfunction was assayed using 53BP1 immunostaining combined with telomere FISH as described (11) . Images were obtained on a Zeiss Axioskop. For telomere dysfunction studies, a DeltaVision Elite system (GE Healthcare) controlling a Scientific CMOS camera (pco.edge 5.5) was used to analyze images at 0.2-μm z-sections which subsequently were deconvolved. Immunohistochemistry was performed using a Vectastain Elite ABC kit (Vector Laboratories). All microscopy imaging and analysis was performed blinded to genotype.
Pulmonary Function, Histology, and Bronchoalveolar Lavage. Pulmonary function and mean linear intercept studies were performed as previously described (8) . Qualitative pathological examination was performed after slides were blinded, and inflammation severity was scored on a scale of 0 to 4 with 0 representing no inflammation and 4 representing very severe inflammation. Bronchoalveolar lavage fluid was collected by lavaging the lung twice with 0.75 mL of PBS. Samples were centrifuged to recover cells, pellets were resuspended in PBS-2%FBS, and viable cells were counted using a hemocytometer. Differential counts were performed on Cytospin preparations stained with a Hema 3 stain (Thermo Fisher). Histopathologic analysis of lung sections was performed by two of the authors (J.K.A. and R.M.T.) including a board-certified pathologist (R.M.T.). Parenchymal macrophages were quantified as described previously (8) . To examine for fibrosis, we performed Masson trichrome staining and measured collagen mRNA levels on whole-lung lysates. To measure the extent of epithelial branching, we captured calibrated images and measured the number of independent epithelial branches identified by E-cadherin immunohistochemistry per lung area.
Microarray Analysis. Transcriptional profiling of purified AEC2 cells was performed using Mouse Exon 1.0 ST Arrays (Affymetrix) at the Johns Hopkins Microarray Facility. Total RNA (10 ng) was amplified using the Nugen Pico WTA System 2.0 (Nugen). Affymetrix CEL file data were extracted and normalized with Partek Genomics Suite software using the Robust Multichip Analysis algorithm. To ensure better coverage of all exons in the annotated transcriptome, all 641,138 extended-class probe sets were extracted (based on the Affymetrix Probeset annotation file) and were summarized into 115,838 transcripts.
ANOVA was run comparing transcript expression levels in control and mutant mice, and the 30,769 transcripts with genelevel annotation were selected for further analysis. The log 2 -fold change distribution of these genes then was evaluated to determine their SD up or down from the mean of 0 (i.e., no change). Genes with a change greater than 2 SD, corresponding to a linear fold change of approximately ± 1.37-fold, were considered to have significant differential expression. These 1,713 gene transcripts were uploaded to the Ingenuity Pathway Analysis platform to evaluate their functional relevance in canonical pathways (Table S1) . P values for pathway studies were calculated using Fisher's exact test. Our minimum information about a microarray experiment (MIAME)-compliant microarray data have been deposited in the National Center for Biotechnology Information Gene Expression Omnibus database (Series GSE56892).
Bleomycin Challenge. Mice were anesthetized with ketamine (90 mg/kg) and xylazine (18 mg/kg) (Sigma). The trachea was exposed, and mice were intubated with an 18-gauge cannula. Bleomycin (1.25 U/kg) was delivered, and mice were ventilated immediately to ensure even distribution. A single lot was used for all experiments. Body weight was collected every other day.
Embryo Studies. Embryos were dissected in PBS and fixed overnight in 4% PFA. For staining requiring frozen sections (lineage trace experiment), tissues were fixed for 3 h in 4% PFA, cryoprotected in sucrose, and embedded in optimum cutting temperature compound. EdU (300 μg) (Invitrogen) was injected i.p. 2 h before embryo harvest. For all timed matings, E0.5 was considered to be noon on the day vaginal plugs were observed. Whole-mount studies were performed as previously described (12) . Briefly, lungs were dissected from E14.5 embryos and fixed for 3 h in fresh 4% PFA at 4°C with gentle rocking. Lungs then were dehydrated by a series of methanol washes and were stored in 100% methanol at −20°C until staining was performed. To quantify the morphogenesis defect, we imaged and counted the number of independent epithelial branches per embryonic lung area as identified by E-cadherin staining.
Immunoblot. Protein was isolated from homogenized lungs using a 26-gauge needle in radioimmunoprecipitation assay buffer supplemented with protease and phosphatase inhibitors (Mini Complete and PhosSTOP; Roche). Protein was quantified using a bicinchoninic acid assay (Pierce), separated using SDS-gel electrophoresis, and transferred to PVDF membrane under reducing conditions (Invitrogen). Detection was performed using nearinfrared fluorescent-conjugated secondary antibodies (LI-COR).
Statistics. We used GraphPad Prism v. 5.00 for Windows. Means were compared using Student's t test, and survival was analyzed using the Kaplan-Meier method and the log-rank test. P values <0.05 were considered significant, and all values shown are twosided unless otherwise noted. 
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